Literature DB >> 6183764

Human tumor-associated antigens identified by monoclonal antibodies.

K E Hellström, I Hellström, J P Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183764     DOI: 10.1007/bf00199792

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  111 in total

Review 1.  Cell-mediated immunity to tumor cells.

Authors:  R B Herberman
Journal:  Adv Cancer Res       Date:  1974       Impact factor: 6.242

2.  Demonstration of cell-mediated immunity to human neoplasms of various histological types.

Authors:  I Hellström; K E Hellström; H O Sjögren; G A Warner
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

3.  Common human melanoma-associated antigen(s) detected by monoclonal antibodies.

Authors:  S Carrel; R S Accolla; A L Carmagnola; J P Mach
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

4.  Monoclonal antiodies to human alphafetoprotein.

Authors:  M Uotila; E Engvall; E Ruoslahti
Journal:  Mol Immunol       Date:  1980-06       Impact factor: 4.407

5.  Induction of anti-H-2 antibodies without alloantigen exposure by in vivo administration of anti-idiotype.

Authors:  J A Bluestone; S O Sharrow; S L Epstein; K Ozato; D H Sachs
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

6.  Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.

Authors:  D Herlyn; M Herlyn; Z Steplewski; H Koprowski
Journal:  Eur J Immunol       Date:  1979-08       Impact factor: 5.532

7.  A clinical perspective on cell markers in acute lymphocytic leukemia.

Authors:  W P Bowman; S L Melvin; R J Aur; A M Mauer
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

8.  Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen.

Authors:  I D Bernstein; M R Tam; R C Nowinski
Journal:  Science       Date:  1980-01-04       Impact factor: 47.728

9.  Monoclonal antibodies to two mouse bladder carcinoma antigens.

Authors:  I Hellström; N Rollins; S Settle; P Chapman; W H Chapman; K E Hellström
Journal:  Int J Cancer       Date:  1982-02-15       Impact factor: 7.396

Review 10.  Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.

Authors:  M F Greaves
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

View more
  7 in total

1.  Stimulation of peripheral blood lymphocytes with autologous tumor and serum-derived fractions from patients with laryngeal carcinomas.

Authors:  P Koldovsky; U Koldovsky; J Ebbers; K H Vosteen
Journal:  Arch Otorhinolaryngol       Date:  1986

2.  Selective extraction by 1-butanol of surface glycoprotein antigens from human melanoma cells.

Authors:  S K Liao; J W Smith; P C Kwong
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 3.  Manipulation of host resistance in cancer therapy.

Authors:  R W Baldwin
Journal:  Springer Semin Immunopathol       Date:  1982

Review 4.  Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting.

Authors:  R W Baldwin; M V Pimm
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  The human mixed lymphocyte-tumor cell interaction test. I. Positive autologous lymphocyte proliferative responses can be stimulated by tumor cells as well as by cells from normal tissues.

Authors:  E A Grimm; B M Vose; E W Chu; D J Wilson; M T Lotze; A A Rayner; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 6.  Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.

Authors:  Nikos G Gavalas; Alexandra Karadimou; Meletios A Dimopoulos; Aristotelis Bamias
Journal:  Clin Dev Immunol       Date:  2011-01-24

7.  Imaging mass spectrometry for the precise design of antibody-drug conjugates.

Authors:  Yuki Fujiwara; Masaru Furuta; Shino Manabe; Yoshikatsu Koga; Masahiro Yasunaga; Yasuhiro Matsumura
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.